GeneDx Holdings Corp’s recently made public that its CHIEF FINANCIAL OFFICER Feeley Kevin unloaded Company’s shares for reported $0.49 million on Jul 09 ’25. In the deal valued at $93.00 per share,5,278 shares were sold. As a result of this transaction, Feeley Kevin now holds 3,392 shares worth roughly $0.28 million.
Then, Stueland Katherine sold 3,220 shares, generating $299,460 in total proceeds. Upon selling the shares at $93.00, the Chief Executive Officer now owns 1,720 shares.
Before that, Stueland Katherine sold 9,657 shares. GeneDx Holdings Corp shares valued at $878,181 were divested by the Chief Executive Officer at a price of $90.94 per share. As a result of the transaction, Stueland Katherine now holds 4,940 shares, worth roughly $0.41 million.
Piper Sandler initiated its GeneDx Holdings Corp [WGS] rating to an Overweight in a research note published on July 09, 2025; the price target was $110. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in mid May with a ‘”a Buy”‘ rating. Jefferies also remained covering WGS and has increased its forecast on May 09, 2025 with a “Buy” recommendation from previously “Hold” rating. Wells Fargo started covering the stock on August 28, 2024. It rated WGS as “an Equal weight”.
Price Performance Review of WGS
On Friday, GeneDx Holdings Corp [NASDAQ:WGS] saw its stock fall -5.01% to $82.56. Over the last five days, the stock has lost -9.88%. GeneDx Holdings Corp shares have risen nearly 176.95% since the year began. Nevertheless, the stocks have risen 7.42% over the past one year. While a 52-week high of $117.75 was reached on 04/29/25, a 52-week low of $25.32 was recorded on 05/08/25.
Levels Of Support And Resistance For WGS Stock
The 24-hour chart illustrates a support level at 80.97, which if violated will result in even more drops to 79.38. On the upside, there is a resistance level at 85.58. A further resistance level may holdings at 88.61.
How much short interest is there in GeneDx Holdings Corp?
A steep rise in short interest was recorded in GeneDx Holdings Corp stocks on 2025-06-13, growing by 0.27 million shares to a total of 3.75 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 3.47 million shares. There was a rise of 7.3%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 10, 2024 when Craig Hallum began covering the stock and recommended ‘”a Buy”‘ rating along with a $43 price target.
